OCM
AXSM icon

Orion Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Orion Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50
Closed -$9.13K – 490
2025
Q4 		$9.13K Hold
50
– – ﹤0.01% 394
2025
Q3 		$6.07K Hold
50
– – ﹤0.01% 425
2025
Q2 		$5.22K Hold
50
– – ﹤0.01% 399
2025
Q1 		$5.83K Hold
50
– – ﹤0.01% 380
2024
Q4 		$4.23K Buy
+50
New +$4.6K ﹤0.01% 415

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Orion Capital Management's AXSM Position: Q1 2026 in Review

Orion Capital Management sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 50 shares — an estimated $9.13K sold.

Orion Capital Management first reported a position in AXSM in Q4 2024 and held it in 5 quarters. The position peaked at $9.13K in Q4 2025. 410 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Orion Capital Management reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Orion Capital Management sold 50 Axsome Therapeutics shares in Q1 2026, an estimated $9.13K.
  • Orion Capital Management first reported a position in Axsome Therapeutics in Q4 2024 and held it in 5 quarters.
  • Orion Capital Management's Axsome Therapeutics position peaked at $9.13K in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Orion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.